Answers are grounded in this paper and cite their sources.
Case series examines pulmonary vasodilator therapy outcomes in COPD-associated pulmonary hypertension, suggesting careful patient selection is crucial.
Rationale Pulmonary vasodilator therapy in chronic obstructive pulmonary disease-associated pulmonary hypertension (COPD-PH) remains controversial, and real-world data describing which patients are selected for treatment after invasive hemodynamic confirmation are limited. We present a single-center case series of patients with RHC-confirmed COPD-PH treated with pulmonary vasodilators, focusing on clinical phenotype, hemodynamic profile, treatment patterns, and short-term outcomes. Methods We conducted a retrospective case series of adults with COPD-associated PH identified by right heart catheterization (RHC) between 2018 and 2023. Patients with isolated precapillary PH or combined pre- and postcapillary PH treated with pulmonary vasodilators within 1 month of RHC were included. Outcomes included major adverse cardiovascular events (MACE), all-cause mortality, and pulmonary complications. Results Among 200 patients with COPD-PH and a precapillary component, 14 patients (7%) received pulmonary vasodilator therapy after RHC and comprised the case series. Most had isolated precapillary PH (71%), severe PH by prior criteria (71%), and frequent cardiopulmonary comorbidities. Sildenafil monotherapy was used in 13/14 patients, while one received sildenafil plus macitentan. At 1-year follow-up, 5/13 patients with available data developed MACE, including 3 heart failure hospitalizations and 2 cardiovascular deaths. Among 4 patients with repeat RHC, 3 had higher PVR on follow-up evaluation. Conclusion Pulmonary vasodilator therapy was used in a small, highly selected subset of patients with RHC-confirmed COPD-PH. Treated patients had heterogeneous hemodynamic profiles and frequent cardiovascular events during follow-up, supporting the need for careful phenotyping and prospective studies.
No takes yet. Share an insight, caveat, or question.
Ricaurte et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: